Document ID: chunk:federal_register_of_legislation:F2023L01440:reg:9:p3
Version: federal_register_of_legislation:F2023L01440
Segment Type: reg
Provision Reference: reg 9 (pt 3/6)
Character Range: 13189–16310

before the clinical onset of substance/medication-induced anxiety disorder;
(23)      using a psychoactive chemical or substance at an intoxicant dose, which is associated in the individual with the development of anxiety symptoms, and where the psychoactive chemical or substance was being taken within the 2 days before the clinical onset of substance/medication-induced anxiety disorder;
Note: intoxicant dose is defined in the Schedule 1 – Dictionary.
(24)      having ceased or reduced therapeutic or illicit drug use or other substance use within the 10 days before the clinical onset of substance/medication-induced anxiety disorder;
(25)      having periodic, heavy alcohol consumption for the 3 months before the clinical onset of substance/medication-induced anxiety disorder;
Note: periodic, heavy alcohol consumption is defined in the Schedule 1 – Dictionary.
(26)      having an alcohol use disorder or a substance use disorder at the time of the clinical onset of substance/medication-induced anxiety disorder;
(27)       having smoked tobacco products in an amount of at least 0.5 pack-years before the clinical onset of substance/medication-induced anxiety disorder, and if smoking has ceased before the clinical onset of substance/medication-induced anxiety disorder, then that onset occurred within 3 months of cessation;
Note: one pack-year is defined in the Schedule 1 - Dictionary.
(28)      having an episode of acute cholinergic poisoning from exposure to an organophosphorus ester within the 30 days before the clinical onset of substance/medication-induced anxiety disorder;
Note: acute cholinergic poisoning and organophosphorus ester are defined in the Schedule 1 – Dictionary.
(29)      for persons without a regular caffeine habit, taking at least 200 milligrams of caffeine from beverages, drugs or foods within the 1 hour before the clinical onset of substance/medication-induced anxiety disorder;
Note: regular caffeine habit is defined in the Schedule 1 – Dictionary.
(30)      for persons with a regular caffeine habit, taking at least 400 milligrams of caffeine from beverages, drugs or foods within the 1 hour before the clinical onset of substance/medication-induced anxiety disorder;
Note: regular caffeine habit is defined in the Schedule 1 – Dictionary.
(31)      being a prisoner of war before the clinical worsening of anxiety disorder;
(32)      experiencing a category 1A stressor within the 5 years before the clinical worsening of anxiety disorder;
Note: category 1A stressor is defined in the Schedule 1 – Dictionary.
(33)      experiencing a category 1B stressor within the 5 years before the clinical worsening of anxiety disorder;
Note: category 1B stressor is defined in the Schedule 1 – Dictionary.
(34)      experiencing severe childhood abuse before the clinical worsening of anxiety disorder;
Note: severe childhood abuse is defined in the Schedule 1 – Dictionary.
(35)      experiencing a potentially morally injurious event within the 5 years before the clinical worsening of anxiety disorder;
Note: potentially morally injurious event is defined in the Schedule 1